| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Robust hepatitis C virus infection in vitro.
|
Proc Natl Acad Sci U S A
|
2005
|
14.78
|
|
2
|
Interferon modulation of cellular microRNAs as an antiviral mechanism.
|
Nature
|
2007
|
7.04
|
|
3
|
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.
|
J Virol
|
2007
|
3.57
|
|
4
|
Persistent hepatitis C virus infection in vitro: coevolution of virus and host.
|
J Virol
|
2006
|
2.77
|
|
5
|
A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C.
|
J Hepatol
|
2012
|
1.80
|
|
6
|
Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus.
|
Chem Biol
|
2011
|
1.41
|
|
7
|
Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus.
|
Proc Natl Acad Sci U S A
|
2008
|
1.26
|
|
8
|
Development of robust hepatitis C virus genotype 4 subgenomic replicons.
|
Gastroenterology
|
2012
|
1.25
|
|
9
|
Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection.
|
J Med Chem
|
2014
|
1.16
|
|
10
|
RNAi for treating hepatitis B viral infection.
|
Pharm Res
|
2007
|
1.05
|
|
11
|
Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.
|
J Virol
|
2011
|
1.02
|
|
12
|
Amino acid substitutions in the effector domain of the gamma(1)34.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-alpha.
|
Virology
|
2003
|
1.02
|
|
13
|
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug.
|
Antimicrob Agents Chemother
|
2014
|
0.94
|
|
14
|
Molecular characterizations of an inhibitor of apoptosis from Schistosoma japonicum.
|
Parasitol Res
|
2010
|
0.89
|
|
15
|
In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
|
Antiviral Res
|
2013
|
0.87
|
|
16
|
Molecular cloning and expression profiles of Argonaute proteins in Schistosoma japonicum.
|
Parasitol Res
|
2010
|
0.85
|
|
17
|
Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.
|
Antimicrob Agents Chemother
|
2014
|
0.82
|
|
18
|
Identification of in vivo protein phosphorylation sites in human pathogen Schistosoma japonicum by a phosphoproteomic approach.
|
J Proteomics
|
2011
|
0.80
|
|
19
|
Molecular characterization of a cytokine-induced apoptosis inhibitor from Schistosoma japonicum.
|
Parasitol Res
|
2012
|
0.80
|
|
20
|
An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture.
|
Virology
|
2011
|
0.79
|
|
21
|
[Cloning and expressing of cyclophilin B gene from Schistosoma japonnicum and the analysis of immunoprotective effect].
|
Sheng Wu Gong Cheng Xue Bao
|
2010
|
0.77
|
|
22
|
Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451.
|
Antimicrob Agents Chemother
|
2013
|
0.77
|
|
23
|
Evaluation of protective immune response in mice by vaccination the recombinant adenovirus for expressing Schistosoma japonicum inhibitor apoptosis protein.
|
Parasitol Res
|
2014
|
0.76
|
|
24
|
Molecular characterization of SjBIRP, another apoptosis inhibitor, from Schistosoma japonicum.
|
Parasitol Res
|
2014
|
0.75
|
|
25
|
Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection.
|
J Med Chem
|
2016
|
0.75
|